← Leaderboards
Megan M Wyatt
Medical University Of South Carolina
$531,713
Attributed
$531,713
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $108.1K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$531,713 · 1
By mechanism
R50$531,713 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Daohong Zhou$16,846,361
- Stephen A Duncan$28,157,111
- Sophie Paczesny$15,189,813
- Denis C Guttridge$20,928,940
- Shikhar Mehrotra$11,720,155
Others in their field
Other Emerging Leaders on “Award”
- Valerie Koch · University Corporation For Atmospheric Res$265,601,376
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- John E West · University Of Texas At Austin$131,399,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Joy Williamson-Lott · University Of Washington$69,987,326
Research focus
AwardBiopsyCancer CenterCancer ImmunotherapyCancer PatientCareerCd28 GeneCd4 Positive T LymphocytesCellsCellular TransductionClinically SignificantCollaborationsCollegeCrispr/Cas TechnologyDipeptidyl-Peptidase IvDipeptidyl PeptidasesDoctor Of PhilosophyEnzymesExhibitsExperimental StudyFutureGenerationsGrantAdoptive Immunotherapy
Grant awards (5)
Research Specialist Support of a Well-Established Cancer Immunotherapy Research Program Focused on Improving Adoptive T Cell Therapy (ACT)$108,145
R50 · FY2022 · CA · contact PI
Research Specialist Support of a Well-Established Cancer Immunotherapy Research Program Focused on Improving Adoptive T Cell Therapy (ACT)$108,145
R50 · FY2021 · CA · contact PI
Research Specialist Support of a Well-Established Cancer Immunotherapy Research Program Focused on Improving Adoptive T Cell Therapy (ACT)$108,145
R50 · FY2020 · CA · contact PI
Research Specialist Support of a Well-Established Cancer Immunotherapy Research Program Focused on Improving Adoptive T Cell Therapy (ACT)$103,639
R50 · FY2019 · CA · contact PI
Research Specialist Support of a Well-Established Cancer Immunotherapy Research Program Focused on Improving Adoptive T Cell Therapy (ACT)$103,639
R50 · FY2018 · CA · contact PI